Structure

Physi-Chem Properties

Molecular Weight:  386.17
Volume:  391.765
LogP:  4.638
LogD:  4.077
LogS:  -5.7
# Rotatable Bonds:  5
TPSA:  55.38
# H-Bond Aceptor:  6
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.753
Synthetic Accessibility Score:  3.527
Fsp3:  0.455
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.764
MDCK Permeability:  6.479614967247471e-05
Pgp-inhibitor:  0.995
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.001
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.077

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.103
Plasma Protein Binding (PPB):  88.60665130615234%
Volume Distribution (VD):  1.236
Pgp-substrate:  4.241413116455078%

ADMET: Metabolism

CYP1A2-inhibitor:  0.12
CYP1A2-substrate:  0.961
CYP2C19-inhibitor:  0.948
CYP2C19-substrate:  0.917
CYP2C9-inhibitor:  0.889
CYP2C9-substrate:  0.876
CYP2D6-inhibitor:  0.666
CYP2D6-substrate:  0.917
CYP3A4-inhibitor:  0.971
CYP3A4-substrate:  0.878

ADMET: Excretion

Clearance (CL):  12.694
Half-life (T1/2):  0.218

ADMET: Toxicity

hERG Blockers:  0.13
Human Hepatotoxicity (H-HT):  0.137
Drug-inuced Liver Injury (DILI):  0.895
AMES Toxicity:  0.156
Rat Oral Acute Toxicity:  0.021
Maximum Recommended Daily Dose:  0.045
Skin Sensitization:  0.702
Carcinogencity:  0.539
Eye Corrosion:  0.004
Eye Irritation:  0.032
Respiratory Toxicity:  0.155

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC136750

Natural Product ID:  NPC136750
Common Name*:   Rel-Saurufurin B
IUPAC Name:   6-[(2R,3R,4S,5S)-5-(3,4-dimethoxyphenyl)-3,4-dimethyloxolan-2-yl]-4-methoxy-1,3-benzodioxole
Synonyms:  
Standard InCHIKey:  YCVPIUIGBBJALE-WVGOSAFVSA-N
Standard InCHI:  InChI=1S/C22H26O6/c1-12-13(2)21(15-9-18(25-5)22-19(10-15)26-11-27-22)28-20(12)14-6-7-16(23-3)17(8-14)24-4/h6-10,12-13,20-21H,11H2,1-5H3/t12-,13+,20-,21+/m0/s1
SMILES:  C[C@H]1[C@@H](C)[C@H](c2cc(c3c(c2)OCO3)OC)O[C@@H]1c1ccc(c(c1)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3104950
PubChem CID:   76310172
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0003686] Furanoid lignans
        • [CHEMONTID:0001604] Tetrahydrofuran lignans
          • [CHEMONTID:0003423] 7,7'-epoxylignans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. PMID[10924192]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. PMID[11754613]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. root n.a. PMID[14750033]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. PMID[15482936]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota roots n.a. n.a. PMID[18841903]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota Roots n.a. n.a. PMID[24359277]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota Aerial Parts n.a. n.a. PMID[24387347]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. PMID[31642320]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO20323 Saururus chinensis Species Saururaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 85000.0 nM PMID[458797]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 56000.0 nM PMID[458797]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 37200.0 nM PMID[458797]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 98.9 % PMID[458797]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 80.3 % PMID[458797]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 75.6 % PMID[458797]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC136750 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC266848
0.9921 High Similarity NPC261812
0.9921 High Similarity NPC72046
0.9921 High Similarity NPC65183
0.9844 High Similarity NPC189474
0.9841 High Similarity NPC192255
0.9766 High Similarity NPC31530
0.969 High Similarity NPC25333
0.969 High Similarity NPC148893
0.969 High Similarity NPC49235
0.9615 High Similarity NPC121651
0.9609 High Similarity NPC7744
0.9603 High Similarity NPC226862
0.9603 High Similarity NPC165128
0.9603 High Similarity NPC82862
0.9603 High Similarity NPC158471
0.9603 High Similarity NPC57119
0.9603 High Similarity NPC222127
0.9542 High Similarity NPC185908
0.9531 High Similarity NPC82111
0.9531 High Similarity NPC227160
0.9524 High Similarity NPC8050
0.9524 High Similarity NPC473093
0.9524 High Similarity NPC473092
0.9474 High Similarity NPC312199
0.947 High Similarity NPC113550
0.9466 High Similarity NPC11453
0.9453 High Similarity NPC233224
0.9453 High Similarity NPC271208
0.9449 High Similarity NPC328682
0.9449 High Similarity NPC281864
0.9449 High Similarity NPC54321
0.9444 High Similarity NPC112571
0.9444 High Similarity NPC50683
0.9444 High Similarity NPC285725
0.9403 High Similarity NPC472562
0.9403 High Similarity NPC80326
0.9398 High Similarity NPC216434
0.9398 High Similarity NPC46591
0.9398 High Similarity NPC103448
0.9398 High Similarity NPC177868
0.9394 High Similarity NPC283949
0.9389 High Similarity NPC150534
0.9385 High Similarity NPC1474
0.9385 High Similarity NPC196937
0.9333 High Similarity NPC298317
0.9333 High Similarity NPC255566
0.9328 High Similarity NPC300798
0.9328 High Similarity NPC58137
0.9318 High Similarity NPC143895
0.9308 High Similarity NPC100223
0.9308 High Similarity NPC158526
0.9308 High Similarity NPC129687
0.9308 High Similarity NPC171928
0.9308 High Similarity NPC33611
0.9308 High Similarity NPC16830
0.9291 High Similarity NPC9891
0.9291 High Similarity NPC88297
0.9291 High Similarity NPC186845
0.9286 High Similarity NPC18449
0.9286 High Similarity NPC121783
0.9286 High Similarity NPC34902
0.9259 High Similarity NPC311057
0.9259 High Similarity NPC174522
0.9259 High Similarity NPC287124
0.9259 High Similarity NPC474295
0.9254 High Similarity NPC226547
0.9254 High Similarity NPC56091
0.9242 High Similarity NPC474139
0.9197 High Similarity NPC180953
0.9191 High Similarity NPC185071
0.9191 High Similarity NPC12728
0.9191 High Similarity NPC474808
0.9173 High Similarity NPC32189
0.9167 High Similarity NPC90083
0.9167 High Similarity NPC170779
0.9167 High Similarity NPC47181
0.916 High Similarity NPC219671
0.916 High Similarity NPC259742
0.916 High Similarity NPC104077
0.916 High Similarity NPC147616
0.9124 High Similarity NPC166884
0.9124 High Similarity NPC141569
0.9124 High Similarity NPC477701
0.9118 High Similarity NPC176586
0.9118 High Similarity NPC210354
0.9104 High Similarity NPC196420
0.9104 High Similarity NPC474039
0.9098 High Similarity NPC236522
0.9098 High Similarity NPC18576
0.9098 High Similarity NPC142547
0.9098 High Similarity NPC126409
0.9098 High Similarity NPC99572
0.9098 High Similarity NPC135777
0.907 High Similarity NPC158737
0.9058 High Similarity NPC205316
0.9058 High Similarity NPC477702
0.9048 High Similarity NPC80241
0.9048 High Similarity NPC301641
0.9048 High Similarity NPC57268
0.9048 High Similarity NPC172676
0.9048 High Similarity NPC126935
0.9048 High Similarity NPC312713
0.9048 High Similarity NPC65933
0.9048 High Similarity NPC216929
0.9037 High Similarity NPC9068
0.9037 High Similarity NPC88640
0.9037 High Similarity NPC193666
0.9037 High Similarity NPC123526
0.903 High Similarity NPC25695
0.903 High Similarity NPC78047
0.903 High Similarity NPC172818
0.9023 High Similarity NPC185680
0.9023 High Similarity NPC145722
0.9023 High Similarity NPC256776
0.9008 High Similarity NPC237169
0.9008 High Similarity NPC470624
0.9008 High Similarity NPC63574
0.8993 High Similarity NPC212890
0.8986 High Similarity NPC239254
0.8986 High Similarity NPC191158
0.8986 High Similarity NPC50696
0.8986 High Similarity NPC177644
0.8986 High Similarity NPC172171
0.8978 High Similarity NPC151423
0.8978 High Similarity NPC40237
0.8963 High Similarity NPC469981
0.8963 High Similarity NPC101807
0.8955 High Similarity NPC24490
0.8955 High Similarity NPC174191
0.8955 High Similarity NPC165155
0.8955 High Similarity NPC141765
0.8955 High Similarity NPC34103
0.8947 High Similarity NPC58585
0.8947 High Similarity NPC158331
0.8936 High Similarity NPC51328
0.8936 High Similarity NPC55158
0.8936 High Similarity NPC286235
0.8931 High Similarity NPC476748
0.8921 High Similarity NPC178014
0.8921 High Similarity NPC11422
0.8921 High Similarity NPC474749
0.8921 High Similarity NPC42716
0.8921 High Similarity NPC475868
0.8913 High Similarity NPC474288
0.8913 High Similarity NPC218510
0.8913 High Similarity NPC76415
0.8898 High Similarity NPC477886
0.8897 High Similarity NPC156376
0.8889 High Similarity NPC344161
0.8889 High Similarity NPC197166
0.8881 High Similarity NPC474478
0.8881 High Similarity NPC287745
0.8872 High Similarity NPC175067
0.8872 High Similarity NPC471505
0.8872 High Similarity NPC204215
0.8872 High Similarity NPC475856
0.8865 High Similarity NPC301961
0.8865 High Similarity NPC248132
0.8865 High Similarity NPC166584
0.8865 High Similarity NPC130449
0.8865 High Similarity NPC71726
0.8857 High Similarity NPC162193
0.8857 High Similarity NPC154971
0.8857 High Similarity NPC252286
0.8849 High Similarity NPC92693
0.8849 High Similarity NPC187774
0.8849 High Similarity NPC326144
0.8849 High Similarity NPC472713
0.8849 High Similarity NPC118385
0.8849 High Similarity NPC218841
0.8849 High Similarity NPC475000
0.8849 High Similarity NPC473046
0.8849 High Similarity NPC472712
0.8846 High Similarity NPC213711
0.8846 High Similarity NPC40352
0.8846 High Similarity NPC206882
0.8841 High Similarity NPC230538
0.8841 High Similarity NPC103637
0.8841 High Similarity NPC41782
0.8841 High Similarity NPC246947
0.8841 High Similarity NPC229172
0.8841 High Similarity NPC36531
0.8832 High Similarity NPC284464
0.8828 High Similarity NPC261661
0.8824 High Similarity NPC166184
0.8815 High Similarity NPC101624
0.8815 High Similarity NPC184938
0.881 High Similarity NPC254625
0.881 High Similarity NPC475961
0.881 High Similarity NPC119949
0.8806 High Similarity NPC112237
0.8803 High Similarity NPC85141
0.8803 High Similarity NPC35877
0.8803 High Similarity NPC95392
0.8803 High Similarity NPC55715
0.8797 High Similarity NPC158079
0.8797 High Similarity NPC40432
0.8797 High Similarity NPC115207
0.8797 High Similarity NPC469698

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC136750 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.875 High Similarity NPD3705 Approved
0.8507 High Similarity NPD3027 Phase 3
0.8389 Intermediate Similarity NPD4967 Phase 2
0.8389 Intermediate Similarity NPD4965 Approved
0.8389 Intermediate Similarity NPD4966 Approved
0.8333 Intermediate Similarity NPD5283 Phase 1
0.8278 Intermediate Similarity NPD6234 Discontinued
0.8188 Intermediate Similarity NPD37 Approved
0.812 Intermediate Similarity NPD2981 Phase 2
0.806 Intermediate Similarity NPD2983 Phase 2
0.806 Intermediate Similarity NPD2982 Phase 2
0.7973 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7956 Intermediate Similarity NPD3018 Phase 2
0.7935 Intermediate Similarity NPD7199 Phase 2
0.7929 Intermediate Similarity NPD1613 Approved
0.7929 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD7228 Approved
0.7877 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.782 Intermediate Similarity NPD1357 Approved
0.777 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD7240 Approved
0.7698 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD4908 Phase 1
0.7632 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6674 Discontinued
0.7584 Intermediate Similarity NPD7124 Phase 2
0.7535 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD5494 Approved
0.7518 Intermediate Similarity NPD1610 Phase 2
0.7517 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD3384 Approved
0.7484 Intermediate Similarity NPD3383 Approved
0.7484 Intermediate Similarity NPD3382 Approved
0.7483 Intermediate Similarity NPD1375 Discontinued
0.7469 Intermediate Similarity NPD3818 Discontinued
0.7451 Intermediate Similarity NPD1653 Approved
0.7447 Intermediate Similarity NPD2861 Phase 2
0.7415 Intermediate Similarity NPD3539 Phase 1
0.7407 Intermediate Similarity NPD5536 Phase 2
0.7397 Intermediate Similarity NPD6111 Discontinued
0.7391 Intermediate Similarity NPD1091 Approved
0.7389 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD3540 Phase 1
0.7365 Intermediate Similarity NPD7266 Discontinued
0.7365 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD5058 Phase 3
0.732 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD5111 Phase 2
0.7292 Intermediate Similarity NPD5110 Phase 2
0.7292 Intermediate Similarity NPD5109 Approved
0.7273 Intermediate Similarity NPD7074 Phase 3
0.7267 Intermediate Similarity NPD4237 Approved
0.7267 Intermediate Similarity NPD4236 Phase 3
0.7261 Intermediate Similarity NPD1934 Approved
0.726 Intermediate Similarity NPD3657 Discovery
0.723 Intermediate Similarity NPD4108 Discontinued
0.7226 Intermediate Similarity NPD4210 Discontinued
0.7226 Intermediate Similarity NPD1548 Phase 1
0.7219 Intermediate Similarity NPD4110 Phase 3
0.7219 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7218 Intermediate Similarity NPD228 Approved
0.7215 Intermediate Similarity NPD2978 Approved
0.7215 Intermediate Similarity NPD2977 Approved
0.7212 Intermediate Similarity NPD7054 Approved
0.7192 Intermediate Similarity NPD3620 Phase 2
0.7192 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD4005 Discontinued
0.7172 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD3817 Phase 2
0.7169 Intermediate Similarity NPD7472 Approved
0.7163 Intermediate Similarity NPD4749 Approved
0.7163 Intermediate Similarity NPD5327 Phase 3
0.7153 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4675 Approved
0.7134 Intermediate Similarity NPD7028 Phase 2
0.7134 Intermediate Similarity NPD4678 Approved
0.7133 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD7157 Approved
0.7125 Intermediate Similarity NPD3882 Suspended
0.7122 Intermediate Similarity NPD5125 Phase 3
0.7122 Intermediate Similarity NPD5126 Approved
0.7121 Intermediate Similarity NPD2684 Approved
0.7118 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7466 Approved
0.7105 Intermediate Similarity NPD6331 Phase 2
0.7103 Intermediate Similarity NPD4625 Phase 3
0.7097 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD4357 Discontinued
0.7075 Intermediate Similarity NPD4060 Phase 1
0.7073 Intermediate Similarity NPD5242 Approved
0.707 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD3022 Approved
0.7068 Intermediate Similarity NPD3021 Approved
0.7067 Intermediate Similarity NPD2161 Phase 2
0.7067 Intermediate Similarity NPD3454 Phase 3
0.7067 Intermediate Similarity NPD2438 Suspended
0.7062 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD5585 Approved
0.7047 Intermediate Similarity NPD6896 Approved
0.7047 Intermediate Similarity NPD6895 Approved
0.7042 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD7808 Phase 3
0.7039 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD5535 Approved
0.7037 Intermediate Similarity NPD7843 Approved
0.7027 Intermediate Similarity NPD6355 Discontinued
0.7027 Intermediate Similarity NPD5735 Approved
0.7024 Intermediate Similarity NPD6797 Phase 2
0.7019 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5844 Phase 1
0.7 Intermediate Similarity NPD17 Approved
0.7 Intermediate Similarity NPD2801 Approved
0.7 Intermediate Similarity NPD5588 Approved
0.7 Intermediate Similarity NPD7680 Approved
0.6993 Remote Similarity NPD6658 Clinical (unspecified phase)
0.6993 Remote Similarity NPD3892 Phase 2
0.6982 Remote Similarity NPD7251 Discontinued
0.6982 Remote Similarity NPD6559 Discontinued
0.6975 Remote Similarity NPD4381 Clinical (unspecified phase)
0.697 Remote Similarity NPD3926 Phase 2
0.6968 Remote Similarity NPD5297 Approved
0.6959 Remote Similarity NPD2979 Phase 3
0.6959 Remote Similarity NPD2238 Phase 2
0.6957 Remote Similarity NPD5353 Approved
0.6954 Remote Similarity NPD2796 Approved
0.6944 Remote Similarity NPD5005 Approved
0.6944 Remote Similarity NPD5006 Approved
0.6941 Remote Similarity NPD4338 Clinical (unspecified phase)
0.694 Remote Similarity NPD5451 Approved
0.6936 Remote Similarity NPD7243 Clinical (unspecified phase)
0.6933 Remote Similarity NPD919 Approved
0.6933 Remote Similarity NPD4536 Approved
0.6933 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4538 Approved
0.6929 Remote Similarity NPD5691 Approved
0.6928 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6928 Remote Similarity NPD6166 Phase 2
0.6928 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6928 Remote Similarity NPD3060 Approved
0.6928 Remote Similarity NPD5177 Phase 3
0.6923 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6917 Remote Similarity NPD1358 Approved
0.6909 Remote Similarity NPD6232 Discontinued
0.6908 Remote Similarity NPD5762 Approved
0.6908 Remote Similarity NPD5763 Approved
0.6886 Remote Similarity NPD7473 Discontinued
0.6884 Remote Similarity NPD6387 Discontinued
0.6882 Remote Similarity NPD7685 Pre-registration
0.6879 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2922 Phase 1
0.6875 Remote Similarity NPD8651 Approved
0.6871 Remote Similarity NPD7095 Approved
0.6871 Remote Similarity NPD4055 Discovery
0.6867 Remote Similarity NPD2492 Phase 1
0.6857 Remote Similarity NPD1182 Approved
0.6853 Remote Similarity NPD1840 Phase 2
0.6853 Remote Similarity NPD1608 Approved
0.6848 Remote Similarity NPD1247 Approved
0.6846 Remote Similarity NPD4140 Approved
0.6846 Remote Similarity NPD1558 Phase 1
0.6842 Remote Similarity NPD3134 Approved
0.6842 Remote Similarity NPD7549 Discontinued
0.6839 Remote Similarity NPD2219 Phase 1
0.6838 Remote Similarity NPD1137 Approved
0.6838 Remote Similarity NPD1139 Approved
0.6835 Remote Similarity NPD5976 Discontinued
0.6832 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6824 Remote Similarity NPD5718 Phase 2
0.6821 Remote Similarity NPD7097 Phase 1
0.6818 Remote Similarity NPD1652 Phase 2
0.6818 Remote Similarity NPD4162 Approved
0.6816 Remote Similarity NPD4420 Approved
0.6815 Remote Similarity NPD4123 Phase 3
0.6809 Remote Similarity NPD1651 Approved
0.6807 Remote Similarity NPD3787 Discontinued
0.6807 Remote Similarity NPD7229 Phase 3
0.6806 Remote Similarity NPD3685 Discontinued
0.6806 Remote Similarity NPD4359 Approved
0.68 Remote Similarity NPD5124 Phase 1
0.68 Remote Similarity NPD1933 Approved
0.68 Remote Similarity NPD5123 Clinical (unspecified phase)
0.679 Remote Similarity NPD8455 Phase 2
0.6788 Remote Similarity NPD1138 Approved
0.6783 Remote Similarity NPD422 Phase 1
0.6783 Remote Similarity NPD1281 Approved
0.6779 Remote Similarity NPD6233 Phase 2
0.6776 Remote Similarity NPD5960 Phase 3
0.6776 Remote Similarity NPD3748 Approved
0.6774 Remote Similarity NPD4628 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data